Kyverna Therapeutics is a patient-centered, clinical-stage biopharmaceutical company focused on developing cell therapies for patients suffering from autoimmune diseases. The Kyverna therapeutic platform leverages advanced T cell engineering to suppress and eliminate autoreactive immune cells at the origin of autoimmune and inflammatory diseases. Be at the forefront of cell therapy innovation by joining scientists, industry veterans and healthcare visionaries and help transform how autoimmune diseases are treated

The Lifecycle Lead manages one or more development program(s) of the KYV-101 and KYV-102 drug candidate by leading a multidisciplinary/cross-functional team(s) from relevant expert functions, as part of the company's strategy.

Title: Executive Director, Lifecycle Lead

Location: Remote

Reporting to: Chief Product Officer

Responsibilities

Leading the definition and delivery of an integrated asset strategy throughout the lifecycle maximizing the value of the asset/program(s) or group of programs, consistent with corporate & portfolio strategy in partnership with functional experts from research, translational, regulatory, clinical, manufacturing, medical affairs, IP, communication, quality (compliance) and commercial.
Leading the program and program team to achieve the objectives in accordance with quality standards and within timelines validated with governance.
Ensures oversight of the Program budget in partnership with functional heads who are accountable for delivery within budget.
Responsible for all activities related to the program(s) are conducted:

o Within the framework of the agreed asset strategy and the overall strategic objectives of the Company

o With cross-functional alignment of Research, non-clinical & clinical, Manufacturing & Commercial, IP, communication, quality (compliance) representatives

o In compliance with the state-of-the-art and external regulations in force, and good project management practices.

At all phases of planning and implementation, ensures appropriate validation by and reporting to governance according to company processes. Owns the integrated strategy for the asset. Is responsible for ensuring the validation of integrated development plan by key stakeholders (senior management/stakeholders and external experts/customers). Ensures cross-functional engagement / way of working to ensure full team alignment and utilizing every member of the team to execute the program strategy. Responsible for the robust assessment of opportunities, risks, in conjunction with the key function leaders, in order to maximize value of the asset/program. Responsible for setting up backup scenarios, as well as « go/no go decision points » to mitigate risks and to present them to Governance meetings. Develops and recommends strategic options to governance. Responsible for appropriate internal communication to Program team and stakeholders. Contributes to and adopts relevant aspects of the company’s portfolio management process. Engages in regular, competent and active communication with key stakeholders as a representative of the company both internally and externally (congress, partnering, and negotiation). Defines & implements Program internal & external communication plans:

o Proposing and conducting communications concerning the results of both scientific and clinical studies in association with the cross-functional team.

o Ensuring consistency across Program messages for external communication.

o Owns all Program Documents relating to the development of the drug candidate as required by Governance, Quality, Compliance & PMO guidance.

Key program deliverables, developed with cross-functional expert team, include:

o Integrated cross-functional development strategy, objectives & plan, consistently with Target Product Profiles & key value drivers.

o Status Updates for Management e.g. dashboards, reports, highlights at governance, other.

o Program Risks/opportunities and mitigation plans.

o Key Decision Points documentation.

Contributes to key functional Project documentation & deliverables as required by governance, Quality, compliance & PMO guidance, such as the Clinical trial documents, IND file, investigator's brochure, Briefing Documents, scientific publications, scientific collaborations work plans, documentation to support CDMO key decision points, documentation for HA interactions, etc.

Qualifications

PhD or equivalent degree and 10+ years in pharmaceutical industry as a program/LCL lead.
Proven experience in the field of biologics and autoimmune/oncology/hematology. A thorough knowledge of the pharmaceutical business model, of the value chain, especially in a Health Care environment.
Experience of working with research, clinical & non-clinical development or commercial collaborations with alliance partners.
Demonstrated Drug Development knowledge with understanding of the cross functional nature of the role including: Research, Translational Sciences, Clinical, Manufacturing, Commercial and Regulatory.
Strong command of clinical data and able to interpret complex data packets
Experience with NDA, BLA filings and regulatory submissions for different parts of a lifecycle both early and late.
Experience of working in an international environment.
Demonstrated ability to drive initiatives, solve issues, pre-empt problems and achieve objectives.
Ability to multitask and promote objective deliverables in resource constraint environment.
Experience in cross-functional drug development and clinical-stage program management.
Understanding of the drivers of commercial success and the interplay between all customers, patients, physicians, pathologists/regulators payers etc.
Ability to work effectively and manage stakeholders in a smooth & efficient way.
Ability to drive delivery and advance complex global programs despite potentially adverse and changing conditions through effective governance and targeted executive escalation in a matrix organizational set up.
Experience and ability to innovate and guide the team to think and deliver creatively in order to generate value.
Demonstrated expert judgment with the ability to quickly identify, analyze, evaluate, escalate and/or resolve problems, which could negatively impact global program implementation and/or financial results.
Excellent interpersonal and communication skills (verbal and written) with the ability to communicate and motivate with a persuasive, credible presentation style.
Ability to resolve issues/ conflict in a constructive manner.
Ability to develop bold ideas and take calculated risks.
Strong tolerance for ambiguity, agility to adapt to change, confidence to speak-up and challenge appropriately.

The national salary range for this position is from $270,000 to $310,000 USD annually. This salary range is an estimate of what we reasonably expect to pay for this posted position, and the actual salary may vary based on various factors, including without limitation individual education, experience, tenure, skills and abilities, as well as internal equity and alignment with market data. This position is also eligible for bonus, benefits, and participation in Company’s stock option plan.

Kyverna is an Equal Opportunity Employer and prohibits discrimination and harassment of any kind. Kyverna is committed to the principle of equal employment opportunity for all employees and does not discriminate on the basis of race, religion, color, sex, gender identify, sexual orientation, age, non-disqualifying physical or mental disability, national origin, veteran status or any other legally protected status. EOE/AA/Vets

Apply for this job

Kyverna Therapeutics

Latest Jobs

Executive Director, Lifecycle Lead